Methods: Evidence of poly-NPS use with cathinones, seizure information, and literature analyses results on NPS mixtures was systematically gathered from online database sources, including Google Scholar, Scopus, Bluelight, and Drugs-Forum.
| BACKGROUND
In the past decade, the illicit drug market has expanded due to the emergence of a large number of new psychoactive substances (NPS).
At the international level, the focus is on NPS, which may pose a threat to public health. The United Nations (UN) defines NPS as "sub- The recent explosion of NPS on the market is thought to be due, in part, to information on synthesis of failed patents of pharmaceuticals with psychoactive effects becoming freely available over the internet (Karila, Megarbane, Cottencin, & Lejoyeux, 2015) . Increased accessibility to NPS via online markets, anonymity, and discretion of online sale, lower prices compared to illicit narcotics and comparable desired effects and/ or improved activity from controlled drugs of abuse and their legal status in many countries have encouraged psychonauts and drug users to supplement their habit with NPS (EMCDDA, 2015) .
Unlike traditional drugs of abuse such as cocaine and 3,4-methylenedioxymethamphetamine (MDMA or ecstasy), these drugs are often exceptionally complex to detect in the field and therefore provision of targeted clinical treatments to counteract toxicity and overdose is difficult.
The inherently complex nature of NPS with respect to their chemical heterogeneity, sustained emergence of new subcategories, and high prevalence and limited available clinical expertise is contributing to significant public health threats. The patterns of abuse, multiple routes of administration, wide range of potency and actual content consumed often pose numerous unanswered questions upon admission to emergency rooms and mental health units (Schifano, Orsolini, Papanti, & Corkery, 2015) . Furthermore, suspected NPS can contain a pure substance or a mixture of substances, where the coabuse of NPS with other drugs is usually unknown. Therefore, treatment decisions are often challenging and prediction of associated potential risks and harms is often not known until NPS-induced intoxication, poisoning, overdose, and/ or fatalities are eventually reported. Stigma, self-treatment, and lack of awareness of users are known factors that commonly lead to underreporting and lack of knowledge on the size of the problem (Home Office, 2014a) . In addition, due to the fast-moving nature of the NPS market, there is a limited availability of knowledge on the health implications and harms associated with the chronic use of NPS.
In light of the wide diversity of the newly emerging NPS and to enable their identification, in 2014, the United Nations Office on Drugs and Crime (UNODC) reclassified them into 10 categories, with the most popular categories being cannabinoids, phenethylamines, and cathinones (Levissianos, 2014) . The popularity of both synthetic cathinones and cannabinoids was also confirmed in recent literature (Papaseit, Farré, Schifano, & Torrens, 2014) . Reported prevalence studies confirmed that cathinones are more prevalent than cannabinoids in specific populations, for example, among high-risk drug users (Bretteville-Jensen, Tuv, Bilgrei, Fjeld, & Bachs, 2013) . Unlike cannabinoids, symptoms of intoxications resulting from cathinones are longlasting, which may potentiate deaths (Fujita et al., 2016) . This makes the study of cathinones mixtures an important aspect of NPS research in which there is still limited information with regards to their pharmacology, long-term and multidrug use, and unknown health consequences and toxicities (Nelson, Bryant, & Aks, 2014a; Zamengo, Frison, Bettin, & Sciarrone, 2014 ).
| Cathinones
Cathinones are synthetic analogues of the naturally occurring phenethylamine alkaloids present in khat trees (Catha edulis; Hassan, Gunaid, & Murray-Lyon, 2006) . Natural cathinones are amphetaminelike stimulants but with lower potency than amphetamine (Patel, 2015) . The main active components in khat are cathinone (S-(-)-2-amino-1-phenylpropan-1-one) and cathine (1S,2S-norpseudoephedrine).
Natural cathinone is more abundant and potent than cathine. However, it is easily oxidised and transformed into cathine post-harvest (ACMD, 2013; Griffiths et al., 2010) . The potency of khat fades after 36-48 hr as cathinone degrades to cathine hence the interest in synthetic cathinones, which have a longer 'shelf-life' (Corkery, 2016) .
| Emergence of synthetic cathinones
In the 1990s, increased interest developed in the diverted use of first generation synthetic cathinones, for example, bupropion, methylone, and pyrovalerone. Bupropion has low abuse potential with reported cocaine-cues in cocaine users (Vento et al., 2013) . However, ephedrone has an increased abuse potential and has been shown to be more potent than cocaine and cathinone (Valente, de Pinho, de Lourdes, Carvalho, & Carvalho, 2014) . Synthetic cathinones were initially abused in Australia, Canada, Mexico, China, Japan, and some European countries including Finland, Germany, Hungary, Netherlands, and Norway. This was followed by their emergence in the United States and Israel. Following their ban in Israel in 2008, cathinones appeared in greater numbers across 14 European countries . By 2009, the popularity of cathinones worldwide was greater than that of ketamine, phenethylamines, piperazines, plant-based substances, or cannabinoids (UNODC, 2013b), and the public health risk posed by these substances became evident. The ban of the "first generation" cathinones, in the United Kingdom, in 2010, led to the emergence of the "second generation" cathinones often referred to as "NRG." NRG products included naphyrone, a "legal" cathinone at the time. Analysis of NRG products purchased over the internet showed the inclusion of "illegal" cathinones such as mephedrone, flephedrone, butylone, pentylone, 4-methylethcathinone, and 3,4-methylenedioxypyrovalerone (MDPV; Valente et al., 2014) . Despite attempts to legislate against them, the popularity of cathinones continued to increase. By 2011, the use of cathinones in Brazil, Greece, Luxembourg, Moldova, Mongolia, Singapore, and Turkey was being reported (UNODC, 2013a) and in 2010 and 2011, synthetic cathinones along with synthetic cannabinoids were reported as the most consumed types of NPS around the world (Newcombe, 2013 
| Popularity and prevalence of cathinones
Wide diffusion and popularity of synthetic cathinones compared to commonly abused drugs is thought to have been influenced by economic, social, and psychoactive determinants. Users reported that they were good value for money, with fewer side effects due to short duration of action and a "better high" than cocaine, MDMA, and amphetamines, and they were easily obtained, which was perceived as a bonus. Cathinones are not only used recreationally but have also been abused in sports, probably due to their intense stimulant effect (Mazzoni, Robertson, & Rabin, 2014) . Drug users have reported that a cathinone-induced stimulant effect was comparable to methylphenidate at low doses or to a combined effect of both amphetamine and cocaine at high doses (Coppola & Mondola, 2012a) . Users consider cathinones to be equipotent and pharmacologically similar to cocaine, amphetamine and MDMA (EMCDDA-Europol, 2012a ). In addition, cathinones were, at the time, "legal" and hence assumed to be "safe." This meant they did not have the social stigma for users associated with the abuse of illegal drugs. In 2009, the popularity of mephedrone or "bubble" in the United Kingdom soared (Measham, Moore, & Østergaard, 2011) , but the reason for this is not well understood. Users' interviews and surveys postulated that increased popularity and convenience of purchasing mephedrone was linked to the unavailability, high price, and impurity of several common illicit drugs, especially stimulants such as amphetamine, cocaine, and MDMA (ACMD, 2010; Carhart-Harris, King, & Nutt, 2011; Measham, Moore, & Newcombe, 2010) . Although it was originally thought that the rapid growth in interest and use of synthetic cathinones, especially mephedrone, notified at the end of 2000s, was in part due to the large decrease in purity of ecstasy and cocaine and instability of the ecstasy market, as mentioned above, recent studies indicated that instead of replacing or displacing ecstasy and cocaine, mephedrone, and most likely other NPS from this group, appeared to have been added to the established repertoires of psychostimulant narcotics (Schifano, Orsolini, Papanti, & Corkery, 2016b) .
Following its control in the United Kingdom in April 2010, the reported use of mephedrone did decline but it has not disappeared (Lader, 2016; NACDA & DHNI, 2016; Black, Setterfield, & Murray, 2016; Ipsos-MORI, 2015) . If anything, it has now become part of the drug repertoire provided by illicit drug dealers (Shapiro & Daly, 2017) and consumed by users alongside other stimulants. Although now controlled together with MDPV and methylone under schedule 2 of the United Nations Convention on Psychotropic Substances 1971 (UNODC, 2015b), and technically no longer an NPS, mephedrone still requires monitoring and investigating, especially because mephedrone-related dependence and fatalities continue to occur on a regular basis (PHE, 2017; ISD, 2016; ONS, 2016; NRS, 2016; NISRA, 2016) . Synthetic cathinones have been widely prevalent among clubbers, high-risk drug users such as heroin-injecting users, MSM (i.e., men who have sex with men), and abstinence treatment entrants (EMCDDA, 2015; Heikman, Sundström, Pelander, & Ojanperä, 2016) .
'Slamming' (i.e., intravenous administration) cathinones became very popular in group sex because it improves mood and induces sexual disinhibition (Batisse, Grégoire, Marillier, Fortias, & Djezzar, 2016 
| RESULTS AND DISCUSSION
This following section highlights the problem of intentional or unintentional use of multiple NPS mixtures containing cathinones simultaneously or sequentially and the potential risks and harms that may be associated with these unsafe practices. The prevalence of cathinone product adulteration with other NPS, drugs of abuse, active adulterants, or cutting agents is also presented.
Search results on Scopus identified 921 papers, whereas the searches via Google Scholar identified 3000+ papers (2013) (2014) (2015) (2016) .
For this article, 200 papers were identified as relevant. Less than 10 results were identified from the above-mentioned drug fora.
| Simultaneous use of NPS mixtures containing cathinones

| Cathinone mixtures identified
The rapid emergence of uncontrolled, untested, impure NPS compounds constitutes a major public health risk (Karila et al., 2015) . The purity of NPS has been shown to decline over time; a trend observed in particular for the cathinone class of NPS. For example, the than four constituents in the mixture .
Mephedrone samples purchased in south Wales, cut with creatine, monosodium glutamate, and sucrose were 33% pure (Miserez et al., 2014) . Some mephedrone samples in the same study were cut with 4-fluoromethcathinone and 4-methylethcathinone (4-MEC; Miserez et al., 2014) . In Poland, two-thirds of buphedrone samples seized by a law-enforcement raid in 2010 were found to contain 4-MEC and MDPV (Zuba, Adamowicz, & Byrska, 2013) . In a large study investigating 60 NPS purchased over the internet during 2012-2013, a product sold as (2-aminopropyl) benzofuran was found to contain 5-(2-aminopropyl) benzofuran and pyrovalerone (Guirguis, Girotto, Berti, & Stair, 2017) .
In 2015, confidential reports on UK NPS cathinone samples submitted for forensic analysis included both single and multiple cathinones as well as other NPS such as ephedrine, ethylphenidate, ketamine, MDMA, and methamphetamine (Daily, 2016) . In its 2016 risk assessment report, the EMCDDA reported that seized products cutting agents such as calcium carbonate, taurine, and creatine were found in cathinone samples seized in the United Kingdom (Stewart et al., 2012) . Cutting agents used in research studies involving cathinones included sucrose, glucose, lactose, and mannitol (Khreit et al., 2012) . Adulterants such as caffeine, lidocaine, procaine, and benzocaine were found in NRG samples purchased over the internet (Brandt, Freeman, Sumnall, Measham, & Cole, 2011; Brandt, Sumnall, Measham, & Cole, 2010) . Up to 2010, the ACMD reported that both controlled drugs of abuse and NPS substances such as amphetamine, benzylpiperazines, cocaine, and ketamine were co-added as adulterants to cathinone products (ACMD, 2010).
In general, and in a similar manner to illicit drugs , NPS may be formulated into products by being mixed with cutting and bulking agents and fillers, which may have been purposely added.
Some adulterants and bulking agents such as benzocaine, caffeine, lidocaine, phenacetin, and procaine are generally added in combination with NPS and with cathinones in particular (Alotaibi, Husbands, & Blagbrough, 2015; Kavanagh et al., 2012) because they may mimic, enhance, and potentiate the effects of controlled drugs of abuse . From 2012 to 2016, sucrose, glucose, lactose, mannitol, monosodium glutamate, and taurine were common cutting agents associated with UK cathinones seizures; creatine and monosodium glutamate being the most popular (Daily, 2016) . Both monosodium glutamate and taurine are known food supplements, whereas sucrose gives a sweet taste. Adulterants such as 2-and 4-aminoindane and fenfluramine may enhance the stimulant effect of cathinones, whereas 3,4-dimethoxy-N-methylamphetamine may exert benzylpiperazine and MDMA-like effects . Lidocaine is a local anaesthetic and may be incorporated in NPS mixtures for its numbing effect, whereas both benzocaine and procaine have been shown to be used as adulterants for their cocaine-like effect .
Adulterants and cutting agents, which may be co-added or coingested with NPS substances in general to counteract their sideeffects, include calcium carbonate, diltiazem, hydroxizine, metoclopramide, paracetamol, and phenacetin (Coppola & Mondola, 2012a; . For example, benzodiazepines were found to be coingested with MDPV to counteract its excitatory effect (EMCDDA-Europol, 2014) . In cathinone samples, calcium carbonate may be incorporated to counteract stomach acidity, whereas hydroxyzine may be incorporated for its sedative effect (Coppola & Mondola, 2012a) . Diltiazem is a rate-limiting antianginal drug and is potentially co-added to these mixtures to counteract the cardio-stimulant effect induced by stimulants. Arguably, however, diltiazem may be added to drug preparations to 'modulate' the stimulant, including synthetic Adulterants and cutting agents may have similar chemical structures to target drugs in order to add to the complexity of the mixture (Noonan, Tonge, Fenton, Damiano, & Frederick, 2009; Ryder, 2002; Ryder, O'Connor, & Glynn, 2000) and may have a stronger or masking detection signal that the target NPS and hence may hinder identification (Assi, Guirguis, Sheelagh, Fergus, & Stair, 2015; Guirguis et al., 2017) . Typical examples includes the similarity in the chemical structures of nicotinamide and cathinone, stronger detection signal of benzocaine , or masking signal of impurities (e.g., dyes
or cutting agents such as microcrystalline cellulose; Assi et al., 2015; Guirguis et al., 2017) . In 2014, adulterants over which UK law enforcement agencies have gained power to seize if they suspect that they are used for cutting NPS included lidocaine, benzocaine, and phenacetin (Home Office, 2014c). mephedrone in MDMA tablets, MDMA powder, amphetamine, and ketamine; and methylone in MDMA tablets and powder (Giné, Espinosa, & Vilamala, 2014 (Dargan, Sedefov, Gallegos, & Wood, 2011) . Recently, the analysis of illicit samples revealed that they contained alpha-pyrrolidinobutiothiophenone and α-PVP and their bromothienyl analogues (Doi et al., 2016) .
| Mislabelled cathinone mixtures
In addition, NPS are often deliberately branded to imply legality and safe use. However, they may include a mixture of NPS with cutting agents, active adulterants (Zancajo et al., 2014) Similarly, in Estonia, the intake of methcathinone and high levels of potassium permanganate using 'kitchen chemistry' have been shown to induce irreversible progressive neurological damage (Sikk & Taba, 2015) . This shows the potential harm that may arise from the inadvertent consumption of unstated ingredients. Cathinone mixtures distributed as "bath salts" have been shown to contain cathinones and piperazines (Davies et al., 2010; German, Fleckenstein, & Hanson, 2013) , caffeine (Baumann, Partilla, & Lehner, 2013a) or methylone, and MDPV and mephedrone (Gershman & Fass, 2012 (Gershman & Fass, 2012; Schneir et al., 2014) .
The content of some brands have been shown to change over time because of legislation. The same brand may not contain the same NPS over time (van Buskirk, Roxburgh, Bruno, & Burns, 2013; . Bath salts have been shown to be adulterated with 1-benzylpiperazine, amphetamine, benzocaine, caffeine, cocaine, ketamine, lidocaine, opiates, and paracetamol (Cottencin, Rolland, & Karila, 2014; McGraw & McGraw, 2012; Watterson, Hood, Sewalia, Tomek, & Yahn, 2012; Zawilska & Wojcieszak, 2013) . Two products, branded as "cotton cloud" and "energising aromatherapy powder,"
were purchased by researchers from the United States. They were labelled as bath salts and 'potpourri,' respectively. Chemical analysis revealed that the former contained three cathinones: mephedrone, methylone, and MDPV, whereas the latter contained MDPV and caffeine (Spiller, Ryan, Weston, & Jansen, 2011) . Brandt et al. (2010) reported the detection of cathinone mixtures in internet samples misleadingly labelled NRG-1 and NRG-2 undeclared mixtures found in NPS products purchased from the Internet included: 3-fluoromethcathinone (3-FMC) and caffeine; ethcathinone, mephedrone, and caffeine; ethcathinone and mephedrone (Davies et al., 2010) . Three packages were found in a car involved in a car accident, resulting in the death of the driver. The packages were labelled as "ivory speed" and "exclusive dust" with inscriptions "collector's product for field stone rinsing" and were shown to contain mixtures of buphedrone and MDPV . Furthermore, the analysis of mephedrone street samples showed that one capsule marketed by "neorganics," branded as "sub coca 2" contained α-phtalidomipriophenone and 2-fluoromethamphetamine (2-FMA).
Other capsules branded as "neodove" and "sub coca" contained mephedrone, caffeine, N-ethylcathinone, and α-phtalidomipriophenone (Camilleri, Johnston, Brennan, Davis, & Caldicott, 2010) . The analysis of 14 NPS street samples showed that the amounts of active ingredients ranged from 11% to 73%. A sample branded as "recharge" was found to contain 42% mephedrone, whereas another sample branded as "ocean burst" was found to contain 38% total active compounds including ethcathinone, 4-MEC, and butylone (Leffler, Smith, de Armas, & Dorman, 2014) .
In its joint report on MDPV, the EMCDDA-EUROPOL revealed that MDPV products seized in Germany from February 2011 to
November 2013 involved branded products such as "Mojo," "Mitseez,"
"Buzz Powder," "Sweed," "Ivory Wave," "J White Powder Cleaner,"
"wakup," "Yellow Submarine," "XXX," "Buty," "Lionheart," "Rush Hour,"
"Lets play crack inside," "Charlie Sheen," "All Day, All Night-What the fuck," "Highway," "ECKO," Brutal Powder," "Sextacy," "Insomnia," and cathine (Gurdal et al., 2013) . NPS products advertised as "not for human consumption" have been shown to contain cathinone mixtures.
A product labelled as "mosquito repellent" was found to contain MDPV and the cannabinoid 1-pentyl-3-(1-naphthoyl)indole (Adamowicz, Gil, Skulska, & Tokarczyk, 2013) . Branded products Ocean burst Ethcathinone, butylone, and 4-MEC (Leffler et al., 2014) Platinum Naphyrone and caffeine (Kavanagh et al., 2010) Pure NRG Naphyrone and caffeine (Kavanagh et al., 2010) Rush Pentedrone, caffeine, isopentedrone, and methylamine (Araújo et al., 2014) Rush Buphedrone, caffeine, and methylamine (Araújo et al., 2014) Sub coca 2 α-phtalidomipriophenone and 2-fluoromethamphetamine (Camilleri et al., 2010) Sub coca Mephedrone, caffeine, N-ethylcathinone, and α-phtalidomipriophenone (Camilleri et al., 2010) Vanila sky MDPBP, MDPV, and lidocaine (Kavanagh et al., 2010) White fizz 3′,4′-methylenedioxy-α-pyrrolidinobutiophenone, benzedrone, caffeine, 4-MEC, and pentylone (Kavanagh et al., 2010) White ice 3-flephedrone, caffeine, lidocaine (Christie et al., 2014) Note. 3,4-DMMC = 3,4-dimethylmethcathinone; D2PM = Diphenyl-2-pyrrolidinemethanol; MEC = methylethcathinone; MDPV = 3,4-methylenedioxypyrovalerone; α-PVP = α-pyrrolidinopentiophenone.
labelled as "plant feeders," bath salts, or "plant food" have also been
shown to contain cathinone mixtures ( effects of polydrug use and seek maximum mind alteration and disinhibition, known as "the garbage head syndrome" (Iudici, Castelnuovo, & Faccio, 2015) . Polysubstance use has also been practised by drug users in order to counteract the side-effects or prolong the effect(s) of a drug of abuse or to replace a nonavailable, expensive illicit drug or lowpurity drugs (as above; Clayton, 1986) . For instance, a study found that arrested drivers used MDPV to get effects that mimic those of amphetamine (Ojanperä, Heikman, & Rasanen, 2011) . whereas "sippers" preferred sipping alcohol while ingesting mephedrone.
In contrast, "remedy makers" preferred using alcohol following the ingestion of mephedrone to reverse its side-effects.
Polysubstance consumption in a single session is very widely discussed in online drug fora and has been reported in postmortem case reports (Cosbey, Peters, Quinn, & Bentley, 2013; Marinetti & Antonides, 2013) . Discussions on drug fora (Bluelight, 2012) revealed that NPS are co-ingested with numerous drugs of abuse from the known repertoire. In 2010, a survey undertaken in two South London gay dance clubs was able to capture data from 207 clubbers. Of those, 46% and 41% mixed or intended to use mephedrone with MDMA and cocaine, respectively . Postmortem inquests showed that deceased cases have co-ingested up to eight classes of drugs, up to 10 drugs in a session (Marinetti & Antonides, 2013) . The
Lancet has reported polysubstance use in gay and lesbians club and sex "chill-outs" parties. Drugs often consumed during partying included MDMA, mephedrone, cocaine, γ-butyrolactone (GBL), and ketamine (Kirby & Thornber-Dunwell, 2013) , whereas drugs preferred in "chemsex" sessions included MDMA, mephedrone, GBL, and methamphetamine (Bourne, Reid, Hickson, Torres-Rueda, & Weatherburn, 2015) . and club drugs, that is, ketamine and MDMA (Wagner et al., 2014) .
Limited information was available from Bluelight and DrugsForum on preferred cathinone combinations. Users reported the intake of mephedrone and heroin, also known as a 'speed-ball' combo (Karila et al., 2015) . Experiences shared over the period between 2010 and 2015 included the intake of mephedrone with Viagra (Cialis) to boost libido, and the intake of 4-MEC with "weed" and GBL during chemsex sessions (Drugs-Forum, 2010a , 2010b . In contrast, a user shared his experience with a methylone, 4-FA, and 3,4-methylenedioxeamphetamine combo and reported suffering from neck and head twitching lasting for 2 months, an adverse effect that reoccurred upon subsequent intake of 4-FA (Bluelight, 2011 (Bluelight, , 2012 .
Furthermore, numerous MDPV combinations were reported. For example, combinations of MDPV with cocaine; amphetamines and methamphetamine due to their entactogenic effects; combinations with cannabis; kratom; other cathinones; alcohol; β-blockers such as propranolol to counteract tachycardia; GBL, GHB and 5-methoxy-Nmethyl-N-isopropyltryptamine to improve libido; zopiclone to enhance visual hallucinations; caffeine for its stimulant effect; famotidine, omeprazole, and domperidone to counteract stomach pain; pregabalin;
opiates; and benzodiazepines for their anxiolytic effect (Coppola & Mondola, 2012b; Katz et al., 2014) . A case study by Bertol et al. Limited information is available on the pharmacology and toxicology of cathinones (Green, King, Shortall, & Fone, 2014; Schifano, Papanti, Orsolini, & Corkery, 2016a; Valente et al., 2014) . Cathinone analogues exhibit various pharmacological effects including stimulant (increasing alertness, euphoria), empathogenic (increased empathy), and antidepressant (improving mood) effects (ACMD, 2010; Erowid, 2013) . Coppola and Mondola (2012a) and Cozzi, Sievert, Shulgin, Jacob, and Ruoho (1999) showed that cathinones may exert their stimulant effect by inhibiting the enzymes tyrosine hydroxylase and tryptophan hydroxylase, which are responsible for the synthesis of DA and 5-HT (Coppola & Mondola, 2012a; Cozzi et al., 1999) . Cathinones also inhibit the reuptake of the neurotransmitters dopamine (DA), sertonin (5-HT) and norepinephrine (NE) by the monoamine transporters, from the synaptic cleft, which results in reduced clearance of neurotransmitters from the cleft. Additionally, they induce the release of newly synthesised monoamines from both the cytoplasm as well as stored monoamines from the synaptic vesicle stores. These pharmacological effects result in reduced concentrations of monoamines in the frontal cortex, hippocampus, and neostriatum (Gygi, Gibb, & Hanson, 1996; Gygi, Fleckenstein, Gibb, & Hanson, 1997; Sparago et al., 1996) .
Cathinones target the monoamine transporters serotonin, dopamine, and NE transporters (SERT, DAT, and NET, respectively) and the nicotinic anticholinergic receptors (e.g., bupropion), in a similar manner to traditional drugs of abuse (Baumann et al., 2012; Simmler et al., 2013a) .
Despite that, many of the newly emerging cathinones are amphetamine derivatives, chemical substitutions on the amphetamine "core structure" alter potency at the NET, DAT, and SERT transporters (Baumann et al., 2012; Cozzi et al., 2013; Eshleman et al., 2013; Iversen et al., 2013; Simmler et al., 2013a; Simmler, Rickli, Hoener, & Liechti, 2014a; Simmler, Rickli, Schramm, Hoener, & Liechti, 2014b) . Therefore, cathinones have been classified based on their pharmacological action (i.e., DAT/SERT inhibition ratio) and comparability to traditional drugs of abuse, in particular,
1. Cocaine-MDMA-mixed cathinones, for example, mephedrone, 4-MEC, methylone, etylone, butylone, and naphyrone. These are substrates for the DAT, SERT and NET. These molecules are associated with an entactogenic, MDMA-like, effect when ingested orally, and with a psychostimulant cocaine-like effect when being administered intranasally (Liechti, 2015) .
2. Methamphetamine-like cathinones, for example, cathinone, methcathinone, flephedrone, ethcathinone, and 3-FMC. These are monoamine transporter substrates with DAT selective profiles, exhibiting high inhibitory potencies at DAT and lower inhibitory potencies at SERT (Simmler et al., 2013b and . They also induce both DA and NE release similar to methamphetamine (Liechti, 2015) . (Simmler et al., 2013b; Eshleman et al., 2013) . Due to these characteristics, these molecules may present with a high abuse potential (Schifano et al., 2016a) .
Interestingly, the para-substituted cathinones, for example, 4-MEC, flephedrone, mephedrone, and 4-bromomethcathinone exhibit a greater serotonergic effect than their amphetamine analogues with flephedrone (4-fluro-cathinone) exhibiting the lowest serotonergic effect in this group (Rickli, Hoener, & Liechti, 2015) . This example shows the impact of substituting various functional groups at different positions on existing cathinone molecular scaffolds. For example, four types of chemical scaffold for cathinones were identified by Zdrazil, Hellsberg, Viereck, and Ecker (2016) highlighting structural variations including substituents of the nitrogen atom, the aromatic ring and the keto group carbon. These variations have been shown to affect selectivity at DAT and SERT (Figure 1 ; Zdrazil et al., 2016) .
| Cathinones in combination with remaining recreational drugs: pharmacological interactions
In most cases, users of cathinones take other drugs as well on the same occasion (Schifano et al., 2016b) , and one could wonder about the rationale of this polydrug abuse. Indeed, cocaine and/or amphetamines and/or ecstasy tablets may be taken in combination with cathinones to maintain arousal and a state of alertness, because the MDMA or serotonergic stimulant entactogenic effects fade away in a few hours (Schifano, 2004) . Potential interaction of cathinones could theoretically occur with prescribing medications as well, for example, with the monoamine oxidase inhibitor moclobemide, which is taken to enhance the effects of ecstasy-like stimulants (Vuori et al., 2003) ; or with selective serotonin reuptake inhibitors (SSRIs). These interactions could facilitate occurrence of the serotonin syndrome (Green, Cross, & Goodwin, 1995) , which can be fatal (Schifano, 2004) . Serotonergic release is intensified by parallel use of dopaminergic stimulants, with the more serious complications (e.g., delirium, seizures, and coma) occurring when serotonergic stimulants are self-administered together with cocaine and amphetamines (Huether, Zhou, & Ruther, 1997; Schifano, 2004) . Moreover, the mixed use of hallucinogens (i.e., ketamine and/or Lysergic acid diethylamide (LSD)) together with stimulants/cathinones can increase occurrence of idiosyncratic/intoxicated "behaviour," such as dangerous driving, with a consequent higher risk of a fatal outcome.
Finally, it is also possible that concurrent use of sedatives (i.e., opiates) might somewhat mitigate the excess of sympathomimetic overactivity observed with stimulants, including cathinones (Schifano, 2004) .
| Toxicity of cathinone mixtures
Because the mode of action of newly emerging cathinones is not fully understood, toxicity intrinsic to individual cathinones or cathinone mixtures is unknown and unpredictable. A survey conducted in a UK emergency setting reported that the number of toxicities resulting from the abuse of NPS increased from seven in 2006 to 98 in 2010.
Eighty-two of these cases showed toxicities resulting from the abuse of synthetic cathinones (Wood, Greene, & Dargan, 2013) . The Euro-DEN Plus project reported that two-thirds of hospital admissions involving NPS were related to cathinones (EMCDDA, 2016a) . Adverse effects related to cathinones could be predicted from their pharmacological activity. For example, the intake of high or multiple doses of the methamphetamine-like cathinones may induce hypertension, hyperthermia, euphoria, and hallucinations (Aarde et al., 2011; Liechti, 2015) . If both MDPV and methamphetamine are taken together, they may induce sympathomimetic toxicity and would bear a high risk of addiction. In addition, the pyrovalerone-like cathinones such as MDPV and α-PVP may induce agitation and hallucination (Spiller et al., 2011; Eiden et al., 2013) . Because MDPV is 10 times more potent than cocaine, it was postulated that it can induce severe hypertension and tachycardia and is associated with a high potential for abuse (Baumann et al., 2013a ).
Furthermore, in silico studies could be performed to predict cathinone toxicity. For example, molecular modelling studies conducted by Gibbons and Zloh (2010) demonstrated that Me-cathinones were less lipophilic than corresponding methamphetamine analogues.
The log P and log BBB values of Me-cathinones were lower than that of methamphetamine with at least one log unit (Gibbons & Zloh, 2010) .
This demonstrated lower ability to cross the BBB than methamphetamines. For this reason and as confirmed in drug surveys, drug users often consume higher doses of cathinones with low lipophilicity (e.g., mephedrone), which could result in repeated dosing (Schifano et al., 2016b ) and inadvertent overdoses, toxicities, and potential fatalities.
Mephedrone has been implicated in fatalities, intoxications resulting from high concentrations, and impaired driving (Cosbey et al., 2013) .
However, methamphetamine has been shown to affect the BBB permeability hence facilitating the passage of coingested NPS to the brain (Northrop & Yamamoto, 2015) . On the other hand, pyrrolidine analogues such as MDPV contain a pyrrolidine group and a tertiary amine group, which infer high lipophilicity and low polarity, and, hence, high permeation across the BBB may potentially occur (Coppola & Mondola, 2012a; Gibbons & Zloh, 2010; Lewin, Seltzman, Carroll, Mascarella, & Reddy, 2013; Simmler et al., 2013b) .
Toxicity resulting from the adulteration of illicit drugs has also been widely reported (Giné et al., 2014) . For example, methylone and butylone, two SSRIs, found in a tablet sold as ecstasy, induced serotonin syndrome and death (Warrick et al., 2012) . to have synergistic toxic effects on Chinese hamster ovary cells, a heterologous system, which expresses monoamine transporters (Sogawa et al., 2011) . Alternatively, methylone and methamphetamine mixtures do not induce an increase in the release of monoamines from chromaffin granules (Sogawa et al., 2011) . Mephedrone and MDPV have been shown to have additive effects, which may prolong toxicity (Cameron, Kolanos, Verkariya, de Felice, & Glennon, 2013) .
Consequences of polydrug intake can lead to the increased risk of toxicity, overdose, death, and crimes (homicides, robberies, and sexual assaults; Rojek, Kłys, Maciów-Głąb, Kula, & Strona, 2014; UNODC, 2014) . Poly-drug ingestion was found to be associated with multidrug resistance, as well as the risk of blood-borne and sexually transmitted infections (Wagner et al., 2014) . The effect of co-ingestion of multiple cathinones or cathinones combined with adulterants, in cathinone mixtures, is unknown and unpredictable; especially given that the actual consumed doses, the actual active drug concentrations in the products ingested, potency, routes of administration, time of onset, and the duration of action are not always known. For instance, a death case was related to two NPS products "aroma liquid" and bath salts and alcohol. Three cathinones (i.e., 4-MeO-PV8, PV9, and 4-MeO-PV9) and diphenidine were contained in the products and were directly implicated in the cause of deaths, under the influence of three coingested benzodiazepines and alcohol (Kudo et al., 2015 The implications of high-risk practices particularly injecting mixtures can be detrimental. For example, the injection of a bath salts product found to incorporate the cathinone 4-MeO-PV8 and the opioid acetyl fentanyl has resulted in the amphetamine-user's death (Yonemitsu, Sasao, Mishima, Ohtsu, & Nishitani, 2016) . The coadministration of mephedrone with heroin led to the death of a 22-year-old Caucasian man (Dickson, Vorce, Levine, & Past, 2010 (Corkery, Schifano, & Ghodse, 2012) . A large study retrospectively reviewed the toxic effects of NPS using postmortem results and criminal casework from January 2010 to December 2012. Results showed that 41% of deaths, where cathinones were implicated, resulted from hangings and mechanical suicides (Blum et al., 2013; Elliott & Evans, 2014) . This is in line with the National Programme on Substance Abuse Deaths findings (Corkery et al., 2012) .
| Symptoms of intoxication by cathinones
Cathinone-related calls to a US poison centre rose sharply from 303 in 2010 to 4,720 in 2011 (Jerry, Collins, & Streem, 2012) , and the symptoms of cathinone intoxication have been extensively published (Coppola & Mondola, 2012a; Khullar, Jain, & Sattari, 2014; Lewin et al., 2013) . Neuro-psychological toxicity is thought to be induced as a result of impairing the function of the central monoamine transporting system (German et al., 2013) . Neuro-psychological symptoms have been shown to be associated with previous exposure to other stimulants such as cocaine and methamphetamine (Spiller et al., 2011) . Psychiatric symptoms include agitation, aggression, anxiety, combative behaviour, confusion, extreme paranoia, delusions, hallucinations, paraesthesia, self-harm, and harm to others; cardiovascular symptoms mainly include sympathomimetic symptoms such as narrow-complex tachycardia, ventricular tachycardia, ventricular fibrillation, systemic hypotension, palpitations, peripheral vasoconstriction, hypertension, chest pain, and electrocardiogram abnormalities (Jerry et al., 2012; Home Office, 2015; Regan, Mitchelson, & Macdonald, 2011; Toxbase, 2014) ; neurologic symptoms include seizures (particularly myoclonus), headache, and tremors; metabolic and blood tests abnormalities: elevated creatine kinase and hypokalaemia; adverse effects lasting more than 24 hr (Jerry et al., 2012; Spiller et al., 2011) ; acidosis (Toxbase, 2014) ; other symptoms include: hyperthermia, blurred vision, mydriasis, nausea and vomiting, abdominal pain, bruxism, and excess sweating (Spiller et al., 2011) . Multicathinone intoxication reported to Toxbase included symptoms of serotonin syndrome, stroke, myocardial infarction, hyponatraemia, rhabdomyolysis, renal and hepatotoxicity, pulmonary oedema, cardiomyopathy, convulsions, raised body temperature, coma, and deaths (Toxbase, 2014 ).
| Proposed treatments of cathinone poisoning
Detection of an NPS poisoning, identification of the type and quantity of NPS consumed are key to determining antidotes and supportive adjunct treatments to save lives and prevent additional fatalities caused by unknown NPS (Motto, 2012) . There are no selective rapid tests to detect NPS in biological fluids, making targeted treatment more challenging (Abdulrahim & Bowden-Jones, 2015) . The unknown composition of NPS mixtures represents a great challenge to the prediction of pharmacokinetics and extent of toxicity may result in a plethora of "behavioural and psychopathological disturbances" (Khullar et al., 2014; Schifano et al., 2015) . Due to lack of universal treatment guidelines, lack of users' cooperation and detection limitations of current test tools, it is challenging to identify newly emerging NPS.
This, in turn, affects treatment decisions and patients presenting to emergency departments following exposure to unknown NPS usually receive supportive treatment for symptom management only (Schifano et al., 2015) . However, one of the biggest challenges is associating specific compounds with symptoms, which is required to accurately assess harms and thus educate and legislate.
Holistic interventions include psychosocial interventions to influence behaviour change and promote abstinence (Abdulrahim & Bowden-Jones, 2015) . In addition, psychological treatment for cooccurring mental health issues can be offered (Abdulrahim & Bowden-Jones, 2015) . Based on the NEPTUNE guidelines (Novel Psychoactive Treatment UK Network), the only available treatment guidelines to date, suggested treatment of acute and chronic harms resulting from the intake of NPS depends on NPS classes. The NEP-TUNE guidelines have classified NPS into four categories: stimulants, depressants/dissociatives, hallucinogens, and synthetic cannabinoids (Abdulrahim & Bowden-Jones, 2015) .
In general, treatment may include antidepressants (to control mood disorder), hypnotic-sedatives (to control agitation), vitamins and nutrients (to prevent encephalopathy; Newcombe, 2013) and naloxone (Atreya, Sun, & Zhao, 2013 (Motto, 2012) .
MDPV-related intoxications were managed using antipsychotics or aripiprazole, quetiapine, risperidone, and olanzapine could be used to control psychosis. Intravenous fluid administration is suggested to treat hyperthermia and control rhabdomyolysis. Both benzodiazepines and cyproheptadine could be used for the management of secretion of antidiuretic hormone (Velez & Benitez, 2015) . Psychosocial interventions are the mainstay of treatment (DH, 2007) . Benzodiazepines have proved to be useful adjunct to treatment (Nelson, Bryant, & Aks, 2014b) .
Raising confidence of health care professions in managing toxicity resulting from NPS is still needed (Wood, Ceronie, & Dargan, 2016) .
Therefore, raising awareness and education of health care professionals on NPS health harms, interventions, harm reduction techniques, and referral pathways are of paramount importance .
| CONCLUSIONS
The effect of the combined intake of cathinone products, whether simultaneous or sequential, could be detrimental to individuals' health. This is because individual NPS products may induce severe toxicity, not to mention the dose, the concentration, the potency and the potential interactions that may occur between the drugs consumed.
Inconsistencies in the composition of identical branded cathinones and the reduced purity pose unpredictable public health risks and high- 
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